Veteran Healthcare Innovator Kevin Weinstein Joins Analyte Health as CEO; Frank Cockerill, MD Named Chief Medical Officer
 
CHICAGO, IL – June 8, 2017 – Analyte Health, the leading platform connecting patients directly to diagnostic services, announced today that it expanded its executive team with the appointment of Kevin Weinstein as Chief Executive Officer. In that capacity, Mr. Weinstein will also join the company’s Board of Directors. Previously, Mr. Weinstein served as the Chief Growth Officer for Valence Health, and held various executive positions with ZirMed, Rise Health and Allscripts.
 
The company also announced that Frank Cockerill, MD, will now focus on leading the company’s clinical and quality efforts as its Chief Medical Officer. Underscoring the importance of clinical excellence for Analyte Health, Dr. Cockerill will continue to serve on the company’s Board of Directors.
 
This executive expansion comes at a time of anticipated growth for the company. Analyte Health recently announced a partnership with telehealth provider Teladoc, Inc. (NYSE: TDOC) to deliver lab diagnostics services, expanded its test menu and completed integration with several additional academic and commercial laboratories. Analyte Health was also recently named a Top 10 Telemedicine Provider for 2017 by Healthcare Tech Outlook. To date, Analyte Health has helped deliver more than 2.2 million test results to individual patients.
 
“Given our posture for growth, we’re thrilled to expand the team to include Kevin,” said Phyllis Whiteley, PhD, Chairwoman of the Board at Analyte Health. “His proven ability to help grow healthcare IT and services businesses is the perfect complement to the clinical and operational expertise within the business.”
 
“I’ve known Analyte Health for a few years, and I am excited to be a part of the company’s next chapter,” said Weinstein. “To be able to join an organization known for innovation and clinical excellence, and to be able to partner with Dr. Cockerill, who is a recognized international leader in diagnostics, is an honor.”
 
Mr. Weinstein will be based in the company’s Chicago headquarters, and Dr. Cockerill, who is based in New York City, will continue to work closely with the company’s clinical team and national network of physicians.
 
About Analyte Health

Analyte Health is the leading national company empowering patients to acquire and understand healthcare diagnostic information as conveniently, confidentially, and cost effectively as possible. By combining a national network of patient service diagnostic centers, a family of online digital assets, and a national telehealth footprint, Analyte Health is helping thousands of consumers every week, and has delivered more than 2.2 million test results since its inception. Analyte Health works with pharmaceutical companies, telehealth providers, diagnostic companies and other healthcare stakeholders to drive clinical compliance and responsible health awareness for consumers.
 
Media Contact:

Richard Foust
richard.foust@analytehealth.com
312.477.3000